ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
百济神州
230.98
+2.84
1.24%
盘后:
229.75
-1.0150
-0.44%
17:21 EDT
成交量:
51.99万
成交额:
1.20亿
市值:
248.81亿
市盈率:
-37.72
高:
234.15
开:
229.30
低:
227.40
收:
228.14
数据加载中...
总览
公司
新闻
公告
百济神州(06160)根据股权计划发行普通股47.98万股
智通财经
·
03-03
百济神州八年累亏591亿日亏2000万 今年营收最高预增40%毛利率80%待考
长江商报
·
03-03
百济神州隐藏了一个真相
市场资讯
·
03-02
277亿元!A股“医药一哥”2024年业绩大增55%
药事纵横
·
03-02
百济神州去年亏损收窄至49.78亿 预计经营利润首次为正
新京报
·
03-01
【券商聚焦】富瑞维持百济神州(ONC)“买入”评级 指其去年业绩强劲
金吾财讯
·
02-28
H股跳涨跑赢同行,百济神州业绩有哪些看点?
财华社
·
02-28
百济神州去年收入增长55%至38亿美元,百悦泽®销售额达26亿美元
财经网
·
02-28
百济神州发布2024年报 全球总收入38亿美元
中国新闻网
·
02-28
百济神州02月28日继续上涨,股价创历史新高
同花顺AI资讯社
·
02-28
百济神州华丽年报背后,为何不见了吴晓滨?
界面
·
02-28
百济神州2024年创收超38亿美元 预计2025年实现经营利润为正
证券日报
·
02-28
【大行评级|瑞银:上调百济神州目标价至330美元 维持“买入”评级】瑞银研究报告指,百济神州去年第四季业绩强劲,胜过市场及该行预期。公司为今年全年提供的收入指引为49亿美元至53亿美元,意味按年增长29%至39%,高过预期。公司亦料今年的经营利润会收支平衡。基于业绩胜预期,该行上调集团今明两年收入预测各13.2%,下调营销、一般及行政支出比例2.7个及1.2个百分点,将美股目标价由289.7美元上调至330美元,维持“买入”评级。
金融界
·
02-28
2024年我国创新药市场超1.1万亿元,港股创新药ETF盘中溢价,百济神州涨超5%
21世纪经济报道
·
02-28
A股百济神州一度大涨超9.5%,股价创历史新高。
美港电讯
·
02-28
百济神州A股大涨9.7%创历史新高,去年净亏同比减至49.8亿元。
金融界
·
02-28
恒生医药ETF重仓股百济神州绩后大涨
每日经济新闻
·
02-28
百济神州盘中涨逾8% 去年全球总收入同比增长55%
新浪港股
·
02-28
百济神州开盘大涨超5% 预计2025年实现经营利润为正
新浪港股
·
02-28
港股异动 | 百济神州(06160)涨超8% 去年全球总收入同比增长55% 预计2025年实现经营利润为正
智通财经
·
02-28
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ONC/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":230.98,"timestamp":1744920000000,"preClose":228.14,"halted":0,"volume":519865,"hourTrading":{"tag":"盘后","latestPrice":229.75,"preClose":230.765,"latestTime":"17:21 EDT","volume":54100,"amount":12495855.13,"timestamp":1744924915084},"delay":0,"floatShares":79387510,"shares":107719405,"eps":-6.124009,"marketStatus":"休市中","change":2.84,"latestTime":"04-17 16:00:00 EDT","open":229.3,"high":234.15,"low":227.3961,"amount":119885584.17555,"amplitude":0.029604,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.124009,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":228.14,"preHourTrading":{"tag":"盘前","latestPrice":233.81,"preClose":228.14,"latestTime":"08:41 EDT","volume":73,"amount":17065.739250000002,"timestamp":1744893686762},"postHourTrading":{"tag":"盘后","latestPrice":229.75,"preClose":230.765,"latestTime":"17:21 EDT","volume":54100,"amount":12495855.13,"timestamp":1744924915084},"volumeRatio":0.7116059393545304,"impliedVol":0.529,"impliedVolPercentile":0.8767},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":79387510,"roa":"-6.07%","roe":"-18.77%","lyrEps":-6.124009,"volumeRatio":0.7116059393545304,"shares":107719405,"dividePrice":0,"high":234.15,"amplitude":0.029604,"preClose":228.14,"low":227.3961,"week52Low":126.9681,"pbRate":"7.47","psRate":"6.53","week52High":287.88,"institutionHeld":0,"latestPrice":230.98,"eps":-6.124009,"divideRate":0,"volume":519865,"delay":0,"ttmEps":-6.124009,"open":229.3,"prevYearClose":184.71,"prevWeekClose":230.36,"prevMonthClose":272.17,"prevQuarterClose":272.17,"fiveDayClose":208.31,"twentyDayClose":262.59,"sixtyDayClose":222.22,"earningDate":1746547200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516852546","title":"百济神州(06160)根据股权计划发行普通股47.98万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516852546","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516852546?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 08:15","pubTimestamp":1740960938,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)发布公告,该公司于2025年2月28日因根据股权计划授出的受限制股份单位获归属(本公司董事除外)而发行普通股47.98万股。于同日,因合资格参与者(公司董事除外)于2025年2月1日至2025年2月28日期间行使购股权而发行普通股合计265.76万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688235","06160","BK1583","BK1161","LU0588546209.SGD","LU0307460666.USD","LU2328871848.SGD","ONC","LU1969619763.USD","BK1588","BK0239","BK1500","BK4139"],"gpt_icon":0},{"id":"2516525294","title":"百济神州八年累亏591亿日亏2000万 今年营收最高预增40%毛利率80%待考","url":"https://stock-news.laohu8.com/highlight/detail?id=2516525294","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516525294?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 08:12","pubTimestamp":1740960721,"startTime":"0","endTime":"0","summary":"总体来看,近8年来,百济神州净利润累计亏损591.12亿元,日均亏损超过2000万元。对于未来发展,百济神州充满信心,公司预计2025年营业收入约为352亿至381亿元,同比增幅约为29%至40%,预计2025年毛利率将处于80%至90%的中位区间。殷敏涉嫌走私严重影响了百济神州声誉,而上市公司近期也有管理人员离职。资料显示,加入百济神州之前,黄智在2007年至2020年期间就职于诺华。这意味着,百济神州预计2025年营业收入增幅约为29%至40%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303082058a25c2ebb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303082058a25c2ebb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","ONC","06160"],"gpt_icon":0},{"id":"2516517961","title":"百济神州隐藏了一个真相","url":"https://stock-news.laohu8.com/highlight/detail?id=2516517961","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516517961?lang=zh_cn&edition=fundamental","pubTime":"2025-03-02 20:13","pubTimestamp":1740917580,"startTime":"0","endTime":"0","summary":" 百济神州在2月27日晚上公布的业绩可以用炸裂来形容。 不过,百济神州期待中的盈利还是没到来。公司经营性亏损大幅收窄53%到5.68亿美元,而且经调整经营利润已经转正。 百济自己给出的财务指引是2025年营收50亿美元。 2024年,泽布替尼在美国的销售额增长了106%,达到19.5亿美元,占据百济神州营收的一半,逐季度的增速平均是20%;欧洲约到美国市场的五分之一。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-02/doc-inenhnuz3227725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ONC","06160","LU1969619763.USD","BK1500","LU2328871848.SGD","LU0307460666.USD","BK1161","BK1588","BK1583","688235","BK0239","LU0588546209.SGD","BK4139"],"gpt_icon":1},{"id":"2516456126","title":"277亿元!A股“医药一哥”2024年业绩大增55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516456126","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516456126?lang=zh_cn&edition=fundamental","pubTime":"2025-03-02 06:03","pubTimestamp":1740866606,"startTime":"0","endTime":"0","summary":"2月27日晚间,百济神州发布2024业绩:Q4营收11亿美元,同比增长78%;全年全球总收入38亿美元,同比增长55%。泽布替尼已在在全球超过70个市场获批,2023年全球销售额达13亿美元,正式跻身“重磅炸弹”药物之列。2024年营收20亿美元,同比增长105%。研发费用研发费用方面,2024年Q4和全年研发支出分别为54万美元,195万美元,均有所增长。目前,百济神州市值达3135亿元,超越恒瑞医药市值3056亿元,成为A股的“医药一哥”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302060507a25a8fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302060507a25a8fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4231","06160","BK4080","BK4139","ADC","688235","ONC"],"gpt_icon":0},{"id":"2516536819","title":"百济神州去年亏损收窄至49.78亿 预计经营利润首次为正","url":"https://stock-news.laohu8.com/highlight/detail?id=2516536819","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516536819?lang=zh_cn&edition=fundamental","pubTime":"2025-03-01 14:09","pubTimestamp":1740809356,"startTime":"0","endTime":"0","summary":"登陆美股近十年之际,百济神州首次在业绩快报中给出了2025年经营利润为正的预计。其2月28日公布的2024年业绩快报显示,公司在报告期内实现营收272.14亿元,同比增长56.2%,净亏损额也收窄至49.78亿元。两款自研产品BTK抑制剂泽布替尼(商品名为百悦泽)和PD-1肿瘤药替雷利珠单抗(商品名为百泽安)仍是公司营收主力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503013333815476.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503013333815476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","LU0588546209.SGD","BK1583","BK1161","06160","LU0307460666.USD","BK4139","ONC","BK1588","LU1969619763.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514329534","title":"【券商聚焦】富瑞维持百济神州(ONC)“买入”评级 指其去年业绩强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2514329534","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514329534?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 20:55","pubTimestamp":1740747332,"startTime":"0","endTime":"0","summary":"金吾财讯 | 富瑞发表报告指,百济神州(ONC)去年业绩强劲,尽管投资者对处方数据差异存在讨论,Brukinsa表现依然超出市场预期,第四季收入8.28亿美元,全年收入达26亿美元,按年增105%,净定价保持稳定。公司对2025年提供指引,料全年收入达49亿美元至53亿美元,即按年增29%至39%,并重申2025年达到经营收入收支平衡的目标。该行表示,下一步将关注即将到来的ASCO更新(CDK4、CDK2、B7H4相关进展)。该行将百济神州目标价由286美元上调至308美元,维持“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/NGY0MmI5YjBmZmE4NTQ4NTQ2MWJlYzY2MzQ2MDk2NDUy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NGY0MmI5YjBmZmE4NTQ4NTQ2MWJlYzY2MzQ2MDk2NDUy.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"285924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","688235","06160"],"gpt_icon":0},{"id":"2516793533","title":"H股跳涨跑赢同行,百济神州业绩有哪些看点?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516793533","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516793533?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 19:51","pubTimestamp":1740743487,"startTime":"0","endTime":"0","summary":"今日早盘港股生物科技板块表现活跃,其中百济神州(06160.HK)表现最为抢眼,一度跳空大涨近8%,此后涨幅回落至3.16%,但表现依然显著强于君实生物(01877.HK)、再鼎医药(09688.HK)、信达生物(01801.HK)等同行。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/1294c2da-f228-42d1-929f-8a8cabdeaef9.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/1294c2da-f228-42d1-929f-8a8cabdeaef9.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67c1a33f23082975a38f607c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1583","BK1161","BK1588","06160","LU0307460666.USD","LU0588546209.SGD","LU2328871848.SGD","LU1969619763.USD","ONC","BK1500","BK4139"],"gpt_icon":0},{"id":"2514344425","title":"百济神州去年收入增长55%至38亿美元,百悦泽®销售额达26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514344425","media":"财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514344425?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 18:31","pubTimestamp":1740738660,"startTime":"0","endTime":"0","summary":"近日,百济神州公布2024年第四季度和全年财务业绩及业务进展。披露2024年第四季度,全球总收入达11亿美元,同比增长78%,全年全球总收入达38亿美元,同比增长55%;GAAP经营亏损持续收窄,实现全年非GAAP经营利润为正。公司2025年全年收入指引为49亿至53亿美元,同时重申预计GAAP经营利润为正且经营活动产生现金流为正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281832039633d974&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281832039633d974&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","BK4139"],"gpt_icon":0},{"id":"2514343462","title":"百济神州发布2024年报 全球总收入38亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514343462","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514343462?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 17:09","pubTimestamp":1740733747,"startTime":"0","endTime":"0","summary":"2月27日晚, 百济神州 发布了2024年第四季度及全年的财务业绩,同时发布A股业绩快报公告。财报显示,百济神州2024年在全球市场持续展示出强劲的增长势头,全年总收入达38亿美元,同比增长55%。值得一提的是,百济神州首次给予财务指引,2025年全年总收入指引为49亿至53亿美元,其中包括收入强劲增长的预期,受益于百悦泽?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228172237a257a78c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228172237a257a78c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK4139","ONC"],"gpt_icon":0},{"id":"2514311411","title":"百济神州02月28日继续上涨,股价创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2514311411","media":"同花顺AI资讯社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514311411?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 16:00","pubTimestamp":1740729616,"startTime":"0","endTime":"0","summary":"02月28日,百济神州股价大涨。截至今日收盘,百济神州上涨5.49%,收盘价为238.41元,收盘价创历史新高。百济神州有限公司是一家全球性、商业阶段的生物科技公司,专注于研究、开发、生产以及商业化创新型药物,主要产品百悦泽((BRUKINSA),BTK抑制剂)、百泽安(抗PD-1单抗)、帕米帕利。近一年公司股价累计上涨85.68%,同期沪深300指数上涨12.75%。根据同花顺问财数据回测分析,前天出现创历史新高的股票,昨天开盘买入平均溢价为1.55%,昨天上涨概率为52.31%;昨天出现创历史新高的股票,今天开盘买入平均溢价为-4.65%,今天上涨概率为14.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160555a25788bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160555a25788bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","BK0239","06160","688235"],"gpt_icon":0},{"id":"2514313104","title":"百济神州华丽年报背后,为何不见了吴晓滨?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514313104","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514313104?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 15:18","pubTimestamp":1740727134,"startTime":"0","endTime":"0","summary":"同时,百济神州首次给出财务指引,预计2025年营收为49亿美元至53亿美元,并重申预计在2025年内实现GAAP经营利润为正,且经营活动产生现金流为正。百济神州美股财报截图。另值得一提的是,北京时间2月27日晚的业绩沟通会上,四名高管代表中仅有百济神州高级副总裁、全球研发负责人汪来一位中国面孔,而百济神州全球总裁兼首席运营官吴晓滨则意外缺席。在此前,类似的业绩发布会吴晓滨均会代表公司出席。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228152037a25776c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228152037a25776c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONC"],"gpt_icon":0},{"id":"2514624883","title":"百济神州2024年创收超38亿美元 预计2025年实现经营利润为正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514624883","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514624883?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 10:40","pubTimestamp":1740710430,"startTime":"0","endTime":"0","summary":"本报讯(记者张敏)2月27日晚间,百济神州有限公司(以下简称“百济神州”)发布了2024年第四季度及全年的财务业绩,同时发布A股业绩快报公告。财报显示,百济神州2024年实现总收入超38亿美元,同比增长55%。产品收入成为推动营收增长的主要动力。具体来看,报告期内,泽布替尼继续在全球市场快速增长,2024年全球销售额总计26亿美元,同比大增105%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502283332829048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","06160","LU0588546209.SGD","ONC","BK1588","BK1583","LU1969619763.USD","BK4139","BK1161","LU2328871848.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2514644713","title":"【大行评级|瑞银:上调百济神州目标价至330美元 维持“买入”评级】瑞银研究报告指,百济神州去年第四季业绩强劲,胜过市场及该行预期。公司为今年全年提供的收入指引为49亿美元至53亿美元,意味按年增长29%至39%,高过预期。公司亦料今年的经营利润会收支平衡。基于业绩胜预期,该行上调集团今明两年收入预测各13.2%,下调营销、一般及行政支出比例2.7个及1.2个百分点,将美股目标价由289.7美元上调至330美元,维持“买入”评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514644713","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514644713?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 10:24","pubTimestamp":1740709492,"startTime":"0","endTime":"0","summary":"瑞银研究报告指,百济神州去年第四季业绩强劲,胜过市场及该行预期。公司为今年全年提供的收入指引为49亿美元至53亿美元,意味按年增长29%至39%,高过预期。公司亦料今年的经营利润会收支平衡。基于业绩胜预期,该行上调集团今明两年收入预测各13.2%,下调营销、一般及行政支出比例2.7个及1.2个百分点,将美股目标价由289.7美元上调至330美元,维持“买入”评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28102448447663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688235","ONC","06160"],"gpt_icon":0},{"id":"2514364535","title":"2024年我国创新药市场超1.1万亿元,港股创新药ETF盘中溢价,百济神州涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514364535","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514364535?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 10:06","pubTimestamp":1740708416,"startTime":"0","endTime":"0","summary":"2月28日,港股主要指数低开低走,创新药板块冲高回落。热门ETF中,港股创新药ETF截至发稿下跌0.69%,成交额近5000万元,换手率超10%,开盘后交投活跃。值得注意的是,金融终端最新数据显示,港股创新药ETF年初至今涨幅超20%。资金流向方面,港股创新药ETF连续两日获资金净流入。结合Frost & Sullivan测算初步统计,2024年我国创新药行业市场规模空间超过1.13万亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228101456abe012e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228101456abe012e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588546209.SGD","LU1969619763.USD","06160","BK1574","BK1500","06978","ONC","LU0307460666.USD","BK1161","BK1583","688235","LU2328871848.SGD","BK1588"],"gpt_icon":0},{"id":"2514369133","title":"A股百济神州一度大涨超9.5%,股价创历史新高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369133","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514369133?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 09:58","pubTimestamp":1740707890,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","LU0588546209.SGD","BK1583","LU2328871848.SGD","399300","BK4139","BK1500","ONC","06160","BK0239","LU1969619763.USD","BK1588","BK1161","688235","LU0307460666.USD"],"gpt_icon":0},{"id":"2514289369","title":"百济神州A股大涨9.7%创历史新高,去年净亏同比减至49.8亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514289369","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514289369?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 09:57","pubTimestamp":1740707836,"startTime":"0","endTime":"0","summary":"百济神州A股大涨9.7%创历史新高,去年净亏同比减至49.8亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28095748446666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159982","BK1500","BK1588","BK1161","LU0588546209.SGD","688235","LU1969619763.USD","BK1583","ONC","06160","BK4139","LU0307460666.USD","399300","LU2328871848.SGD","BK0239"],"gpt_icon":0},{"id":"2514369090","title":"恒生医药ETF重仓股百济神州绩后大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369090","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514369090?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 09:49","pubTimestamp":1740707356,"startTime":"0","endTime":"0","summary":"2月28日早盘,港股关键指数调整,科技股普调,医药股走势分化,恒生医药ETF(159892)重仓股百济神州一度大涨超7%,微创医疗、微创机器人等跌幅靠前。据百济神州公告,其2024年第四季度全球总收入达11亿美元,同比增长78%,全年全球总收入达38亿美元,同比增长55%;GAAP经营亏损持续收窄,实现全年非GAAP经营利润为正。恒生医药ETF跟踪恒生生物科技指数,指数成分股中,药明生物权重11.55%,百济神州权重11.24%,信达生物权重8.28%,康方生物6.38%,创新属性较强。恒生医药ETF联接(A类:016970,C类:016971)每日经济新闻","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095048a2571a02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095048a2571a02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","LU0307460666.USD","BK1161","LU0588546209.SGD","LU1969619763.USD","BK1500","BK1583","688235","06160","BK1588","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514698193","title":"百济神州盘中涨逾8% 去年全球总收入同比增长55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514698193","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514698193?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 09:44","pubTimestamp":1740707040,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 百济神州(06160)盘中涨逾8%,截至发稿,股价上涨5.26%,现报170.10港元,成交额3.18亿港元。\n 百济神州公布2024年第四季度和全年财务业绩,2024年第四季度,公司全球总收入达11.28亿美元,同比增长78%,经调整经营利润7860.3万美元,同比扭亏为盈;2024年全年,公司全球总收入达38.1亿美元,同比增长55%;经调整经营利润4535.6万美元,同比扭亏为盈;GAAP经营亏损持续收窄,实现全年非GAAP经营利润为正。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-28/doc-inemyxcr5800204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1969619763.USD","ONC","BK1500","LU2328871848.SGD","688235","BK1583","06160","BK1588","BK1161","BK4139","LU0588546209.SGD","LU0307460666.USD","BK0239"],"gpt_icon":0},{"id":"2514389369","title":"百济神州开盘大涨超5% 预计2025年实现经营利润为正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389369","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389369?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 09:39","pubTimestamp":1740706740,"startTime":"0","endTime":"0","summary":" 2月28日消息,港股百济神州开盘大涨超5%,现报170.4港元,成交额2.82亿港元。 消息面上,2月27日晚间,百济神州发布了2024年第四季度及全年的财务业绩。财报显示,百济神州2024年在全球市场持续展示出强劲的增长势头,全年总收入达38亿美元,同比增长55%。基于2024年财报业绩表现,百济神州首次给予财务指引,2025年全年总收入指引为49亿至53亿美元,同时,百济神州重申预计GAAP经营利润为正且经营活动产生现金流为正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-02-28/doc-inemyxct2571904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ONC","LU0307460666.USD","BK1161","LU0588546209.SGD","LU1969619763.USD","BK1500","BK1583","688235","06160","BK0239","BK1588","BK4139","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514366363","title":"港股异动 | 百济神州(06160)涨超8% 去年全球总收入同比增长55% 预计2025年实现经营利润为正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514366363","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514366363?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 09:33","pubTimestamp":1740706430,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百济神州涨超8%,截至发稿,涨8.17%,报174.8港元,成交额2.1亿港元。消息面上,百济神州公布2024年第四季度和全年财务业绩,2024年第四季度,公司全球总收入达11.28亿美元,同比增长78%,经调整经营利润7860.3万美元,同比扭亏为盈;2024年全年,公司全球总收入达38.1亿美元,同比增长55%;经调整经营利润4535.6万美元,同比扭亏为盈;GAAP经营亏损持续收窄,实现全年非GAAP经营利润为正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ONC","688235","LU0588546209.SGD","LU0307460666.USD","LU1969619763.USD","BK0239","BK1583","06160","BK1500","BK1161","BK4139","LU2328871848.SGD","BK1588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.74,"defaultRemindTime":1746604800000,"name":null,"time":"盘前","dateTimestamp":1746590400000,"actualEps":null},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-05-11","symbol":"ONC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715400000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.6818,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6818,"analysts":22,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-04-17","current":-38.113584,"percent":0.422535,"low":-46.072488,"twenty":-42.748137,"median":-33.549429,"eighty":-28.784295,"high":-22.805663,"avg":-34.842528,"sd":7.324243,"marketCap":24575105056},"quantilePoints":[{"date":"2025-01-03","current":-23.85925,"twenty":-23.85925,"median":-23.85925,"eighty":-23.85925,"marketCap":19590153584},{"date":"2025-01-10","current":-23.169003,"twenty":-23.588216,"median":-23.51181,"eighty":-23.096335,"marketCap":18938568040},{"date":"2025-01-17","current":-26.770744,"twenty":-26.217794,"median":-23.689854,"eighty":-23.142836,"marketCap":21882666138},{"date":"2025-01-24","current":-28.798988,"twenty":-27.60701,"median":-25.13119,"eighty":-23.374687,"marketCap":23683664763},{"date":"2025-01-31","current":-29.253094,"twenty":-28.895055,"median":-26.770744,"eighty":-23.516999,"marketCap":24179205805},{"date":"2025-02-07","current":-29.699946,"twenty":-29.114029,"median":-28.456686,"eighty":-23.723733,"marketCap":24422582437},{"date":"2025-02-14","current":-29.279798,"twenty":-29.132261,"median":-28.781271,"eighty":-23.9826,"marketCap":24061904635},{"date":"2025-02-21","current":-31.546239,"twenty":-29.269116,"median":-28.798062,"eighty":-24.917918,"marketCap":26058437677},{"date":"2025-02-28","current":-46.072488,"twenty":-30.312806,"median":-28.916244,"eighty":-26.238043,"marketCap":29706894943},{"date":"2025-03-07","current":-42.702936,"twenty":-33.205878,"median":-29.060335,"eighty":-26.487572,"marketCap":27534255325},{"date":"2025-03-14","current":-42.304107,"twenty":-40.627279,"median":-29.228112,"eighty":-26.926934,"marketCap":27277096074},{"date":"2025-03-21","current":-43.63686,"twenty":-41.989697,"median":-29.279798,"eighty":-27.60701,"marketCap":28136436571},{"date":"2025-03-28","current":-43.795471,"twenty":-42.273573,"median":-29.808923,"eighty":-28.393975,"marketCap":28238706493},{"date":"2025-04-04","current":-44.082326,"twenty":-43.290212,"median":-30.877376,"eighty":-28.597906,"marketCap":28423666794},{"date":"2025-04-11","current":-34.741183,"twenty":-42.946887,"median":-33.164233,"eighty":-28.695114,"marketCap":22400628140},{"date":"2025-04-17","current":-38.113584,"twenty":-42.748137,"median":-33.549429,"eighty":-28.784295,"marketCap":24575105056}],"updateTime":1745151047338}}}